INTRODUCTION {#SEC1}
============

Transfer (t) RNA is an adaptor molecule that links the codon in messenger (m) RNA to its corresponding amino acid during protein synthesis. tRNAs contain a number of modified nucleosides that are introduced enzymatically after transcription. To date, more than 100 species of modified nucleosides have been identified in tRNAs from all domains of life ([@B1]). These modifications help to ensure proper tRNA function by stabilizing tertiary structures and modulating decoding properties ([@B2]--[@B6]). A wide variety of chemical modifications are found in the tRNA anticodon loops, especially at the first letter of the anticodon (position 34), the so-called 'wobble' position. Modifications at this position play critical roles in modulating decoding capabilities ([@B4],[@B6],[@B7]). On the other hand, hypermodified purine bases are also found at position 37, 3΄ adjacent to the anticodon; these modifications contribute to decoding processes by ensuring reading-frame maintenance via stabilization of the codon--anticodon interaction on the ribosome ([@B8],[@B9]).

*N*^6^-Threonylcarbamoyladenosine (t^6^A) and its derivatives are modifications found at position 37 of tRNAs responsible for decoding A-starting codons (ANN) in all domains of life (Figure [1A](#F1){ref-type="fig"}) ([@B8],[@B10]). Extensive *in vitro* and *in vivo* studies of the biological functions of t^6^A revealed that this modification has pleiotropic functions in translation, including aminoacylation of tRNAs ([@B11]), tRNA binding to the A-site codon ([@B12]), efficient translocation ([@B13]), reading-frame maintenance ([@B14]) and prevention of leaky scanning of initiation codons and read-through of stop codons ([@B15]). Structural studies revealed that t^6^A enhances anticodon--codon base pairing by cross-strand base stacking of the t^6^A base with the first adenine base of the codon, and stabilizes the anticodon stem--loop structure by stacking with A38 and preventing base-pairing with U33 ([@B16]--[@B19]).

![Chemical synthesis of ct^6^A. (**A**) Chemical structures of t^6^A, oxazolone isoform of cyclic t^6^A, and hydantoin isoform of cyclic t^6^A. (**B**) HPLC elution profiles of chemically synthesized t^6^A and ct^6^A. (**C**) UV spectra of chemically synthesized t^6^A and ct^6^A in H~2~O; for ct^6^A *λ*~min~ = 233, *λ*~max~ = 269; *ε* = 18 900 dm^3^·mol^−1^·cm^−1^.](gkw1189fig1){#F1}

In 2013, a cyclic form of t^6^A (ct^6^A) with a molecular mass of 394 Da (Figure [1A](#F1){ref-type="fig"}) was discovered in bacteria, fungi, protists, and plants ([@B20]). Because ct^6^A is formed via dehydration of t^6^A, it is easily hydrolyzed to t^6^A during handling of tRNA and preparation of nucleosides under mild alkaline conditions ([@B21]). Consequently, t^6^A was discovered \>40 years ([@B10]) before the detection of ct^6^A. When total nucleosides are prepared under neutral conditions in the shortest possible period of time, ct^6^A can be clearly detected, and very little t^6^A is observed in *Escherichia coli* tRNAs ([@B20]), demonstrating that ct^6^A is a bona fide modification in tRNAs from species including *E. coli* and yeast. According to MS and NMR analyses, the chemical structure of ct^6^A was determined to be a cyclic active ester with an oxazolone ring (Figure [1A](#F1){ref-type="fig"}).

ct^6^A is synthesized by tRNA threonylcarbamoyladenosine dehydratase A (TcdA), which catalyzes ATP-dependent dehydration of t^6^A to form ct^6^A ([@B20]). CsdA and CsdE are additional factors required for efficient ct^6^A formation ([@B20]). The yeast homologs of *tcdA, TCD1* and *TCD2*, are required for respiratory cell growth, indicating the physiological importance of ct^6^A ([@B20]). Reporter assays using a Δ*tcdA* strain revealed that ct^6^A is involved in efficient decoding of tRNA^Lys^, and possibly for other tRNAs containing ct^6^A. The crystal structures of TcdA in complex with AMP or ATP have been solved ([@B22],[@B23]), providing insight into the molecular basis of ct^6^A formation.

The discovery of ct^6^A encouraged us to characterize the structural and biochemical contributions of this modification to tRNA functions. For this purpose, we chemically synthesized the 5΄,3΄,2΄-*O*-acetylated derivative of ct^6^A, which was stable under acidic and mild basic conditions ([@B24]). This advance made it feasible to synthesize model RNA oligonucleotides containing ct^6^A for use in further structural and biochemical studies.

In this study, we elaborated simple synthesis of the non-sugar-protected ct^6^A nucleoside using carbodiimide chemistry, and synthesized ct^6^A nucleoside at multi-milligram scale. The resultant ct^6^A was successfully crystallized, and the tertiary structure of the ct^6^A nucleoside was determined by X-ray crystallography. Contrary to our expectation, the crystal structure of ct^6^A contained a hydantoin isoform rather than the previously determined oxazolone isoform (Figure [1A](#F1){ref-type="fig"}). These two isoforms are not differentiated by mass spectrometric analysis and simple NMR studies. The hydantoin structure of synthetic ct^6^A in solution was further confirmed by detailed analysis of ^15^N NMR data and the presence of characteristic absorption bands in IR spectrum. Very surprising result of these structural studies prompted us to investigate whether the hydantoin isoform of ct^6^A is actually present in natural tRNAs. Careful LC/MS co-injection analysis revealed the identity of the synthetic hydantoin ct^6^A with the nucleoside in *E. coli* tRNAs. In addition, we found that hydantoin ct^6^A is susceptible to epimerization under mild alkaline conditions, warning us to avoid conventional deacylation procedure of tRNAs. Based on the structural features of this isoform, the structure--function relationship of ct^6^A37 in tRNAs should be reconsidered.

MATERIALS AND METHODS {#SEC2}
=====================

General information {#SEC2-1}
-------------------

A Waters HPLC (515) system using XTerra^®^ Waters column (MS C8, 5 μm, 4.6 × 150 mm, 100 Å) was used for analytical high-performance liquid column chromatography (HPLC). Chromatography was performed at room temperature, at a flow rate of 1 ml/min, in a gradient of acetonitrile (Solvent B) in 0.1% AcOH/water (Solvent A), as follows: 0% B to 30% B in 0--30 min, and 30% B to 50% B in 30--35 min. The elution profile was monitored by UV absorption at 254 nm using a Waters 996 photodiode array detector. High-resolution mass spectrometry with electrospray ionization was conducted on a Maldi SYNAPT G2-S HDMS (Waters). UV--vis spectra were obtained on an O-2800 Hitachi UV Digilab1 spectrophotometer. IR data were recorded on an FT-IR ALPHA (Bruker) equipped with a Platinum ATR QuickSnap™ module. NMR spectra were recorded in DMSO-*d*~6~ on Bruker Avance II Plus 700 and Bruker DPX-250 spectrometers. Chemical shifts are given as ppm values relative to DMSO, used as an internal reference (2.50 ppm for ^1^H NMR and 39.51 ppm for ^13^C NMR). Signals were assigned based on ^1^H--^1^H COSY, ^1^H--^13^C HSQC, ^1^H--^13^C HMBC and ^13^C DEPT 135 spectra. Signals shapes and multiplicities are indicated as follows: br s = broad singlet, s = singlet, d = doublet, dd = double doublets, ddd = double double doublets, t = triplet, q = quartet, m = multiplet. Scalar coupling constants *J* are given in Hertz (Hz). ^15^N chemical shifts were obtained from analysis of ^1^H--^15^N HSQC and ^1^H--^15^N HMBC spectra, and are given relative to liquid NH~3~. 1D NOE and 2D NOESY spectra were recorded with a mixing time of 300 ms.

Chemical synthesis of t^6^A {#SEC2-2}
---------------------------

t^6^A nucleoside was obtained in good yield according to the procedure reported by Chheda *et al*. ([@B25]--[@B27]). In this method, the exo-amine group of sugar-acetylated adenosine was functionalized with an ethoxycarbonyl group using ethylchloroformate as the electrophile, affording a reactive *N*^6^-carbamate derivative. The ethoxy group of this compound was subsequently substituted with [l]{.smallcaps}-threonine to give sugar-protected t^6^A, which was de-protected by treatment with ammonium-saturated methanol (10 M), yielding the t^6^A nucleoside as the ammonium salt. The t^6^A ammonium salt was then purified by column chromatography on silica gel 60 (230--400 mesh, Sigma-Aldrich). Before cyclization, the t^6^A ammonium salt was converted to the nucleoside with a free carboxylate by cation ion exchange chromatography on Amberlite™ IR120 (H^+^ form). The purity and structure of the t^6^A nucleoside were unambiguously confirmed by analytical HPLC (Figure [1B](#F1){ref-type="fig"}), UV spectrum (Figure [1C](#F1){ref-type="fig"}), IR ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}), ^1^H NMR ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}) and ^13^C NMR ([Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}), and the results were in full agreement with earlier publications ([@B25]--[@B28]).

t^6^A nucleoside bearing [d]{.smallcaps}-*allo*-threonine residue was synthesized according the same procedure as described above for [l]{.smallcaps}-t^6^A isomer. The spectral data of [d]{.smallcaps}-*allo*-t^6^A fully correlated with those reported previously ([@B29]), and they are shown in [Supplementary Figure S4A](#sup1){ref-type="supplementary-material"} (IR), [Supplementary Figure S5A](#sup1){ref-type="supplementary-material"} (^1^H NMR) and [Supplementary Figure S6A](#sup1){ref-type="supplementary-material"} (^13^C NMR).

Chemical synthesis of ct^6^A {#SEC2-3}
----------------------------

t^6^A nucleoside in the free carboxylic form (300 mg, 0.72 mmol) was dissolved in 10 ml of water and mixed with 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide immobilized on a polymer support (EDC-P) (10 equiv, 5.14 g, 7.2 mmol, loading 1.4 mmol/g), followed by vigorous stirring at room temperature for 1 h. After consumption of t^6^A nucleoside was checked by TLC analysis (*n-*BuOH/H~2~O = 85/15, v/v), the reaction was quenched by filtering off the polymer-bounded EDC, followed by three careful washes of the polymer bed with H~2~O (10 ml each time). The filtrate was evaporated to dryness under reduced pressure, and the crude product was subjected to column chromatography on silica gel with a linear gradient of H~2~O (0--3%) in *n*-BuOH to purify ct^6^A nucleoside (140 mg, yield 49%). ct^6^A nucleoside was obtained with similar yield (153 mg, yield 51%) using dimethylformamide (DMF) as a solvent. The purity of ct^6^A and its different lipophilicity relative to t^6^A was confirmed by analytical HPLC (Figure [1B](#F1){ref-type="fig"}), UV spectroscopy (Figure [1C](#F1){ref-type="fig"}), IR ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}), ^1^H NMR ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}), ^13^C NMR ([Supplementary Figure S3B](#sup1){ref-type="supplementary-material"}), and high-resolution MS ([Supplementary Figure S7](#sup1){ref-type="supplementary-material"}).

Cyclization of [d]{.smallcaps}-*allo*-t^6^A was performed with the same procedure as described above to generate [d]{.smallcaps}-*allo*-ct^6^A with slightly lower yield (40%). The structure of [d]{.smallcaps}-*allo*-ct^6^A was confirmed by IR ([Supplementary Figure S4B](#sup1){ref-type="supplementary-material"}), ^1^H NMR ([Supplementary Figure S5B](#sup1){ref-type="supplementary-material"}) and ^13^C NMR ([Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}). HPLC co-injection analysis of [d]{.smallcaps}-*allo*-ct^6^A and [l]{.smallcaps}-ct^6^A mixture showed that both isomers can be clearly separated ([Supplementary Figure S8](#sup1){ref-type="supplementary-material"}).

Single crystal X-ray diffraction analysis {#SEC2-4}
-----------------------------------------

Colorless crystals of ct^6^A (0.30 × 0.10 × 0.05 mm) were obtained from aqueous ethanol (1:1) solution. Single crystal X-ray diffraction data were collected on a Bruker Smart APEX2 diffractometer at 100 K, using an Incoatec Microfocus Source IμS Cu-*K*~α~ (*λ* = 1.54178 Å) as the source of radiation. Integration of the data yielded 14 087 reflections to a 2*θ*~max~ angle of 142°, of which 3384 were independent (*R*~int~ = 0.040), and 3152 reflections with *I* ≥ 2*σ* (*I*). The crystal structure was solved by the intrinsic phasing method. Formula: C~15~H~18~N~6~O~7~·H~2~O, *M*~w~ = 412.37, *Z* = 4, crystal system: orthorhombic, space group: *P2~1~2~1~2~1~, a* = 6.355(1), *b* = 8.173(1), *c* = 33.492(3) Å, *α = β = γ =* 90°, *V* = 1739.4(2) Å^3^, *ρ*~calcd~ = 1.57 g cm^−3^, *μ* = 1.11 mm^−1^. Semi-empirical absorption correction based on multiple scanned equivalent reflections (0.636 \< *T* \< 0.754) was applied. The final anisotropic full-matrix least-squares refinement on *F*^2^ with 342 variables converged at *R*~obs~ = 0.041, *R*~all~ = 0.045, w*R* (*F*^2^) = 0.099 with residual electron density Δ*ρ*~max~ = 0.23 eÅ^−3^ (Δ*ρ*~min~ = -0.25 eÅ^−3^). Positions of all hydrogen atoms were located on a difference Fourier map, and their coordinates and isotropic displacement parameters were refined without restriction, with the exception of hydrogen atoms in water molecules, whose parameters were restrained to the oxygen atom. The correct absolute configuration was provided using a starting material with known configuration. Data collection, reduction, and absorption correction were performed using the*[APEX2]{.smallcaps}* (Version 2014.9, Bruker AXS), *SAINT-PLUS* (Version 8.34A, Bruker AXS), and *[Sadabs]{.smallcaps}* (Version 2014/4, Bruker AXS) programs, respectively. Structure solution and refinement were performed using the *[Shelxtl]{.smallcaps}* suite (Version 2014/6, Bruker AXS). The CDCC 2015 software package (CSD system 2015, Version 5.36, Conquest, Mercury, Mogul) ([@B30]) was utilized for subsequent molecular geometry analysis and visualizations.

Quantum chemistry computations {#SEC2-5}
------------------------------

*Ab initio* energy scans around N1-C6-N6-C13 torsion angle for ct^6^A were performed using the Gaussian09 program with the DFT methodology (Gaussian 09, Revision C.01, Gaussian, Inc., Wallingford CT, 2010). The Truhlar exchange-correlation energy functional M062x and aug-cc-pvdz Dunning\'s basis set were applied to calculate the wave functions. Initial atomic coordinates were those determined for the crystal. For rigid energy scans, a 10° step was set, and then for every conformer an EM062x was computed without molecular geometry optimization. Differences in energies (Δ*E*) compared to *E*~M062x~ for the initial atomic coordinates were calculated, and their highest values are defined as energies of the rotation barrier. For relaxed energy scans, the geometric parameter under investigation was set to a starting value and then iteratively increased by 20°. For each scan step, the optimised molecular geometry *E*~M062x~ was calculated. Conformational energy (Δ*E*) was calculated as the difference between the particular conformer *E*~M062x~ and the lowest value of *E*~M062x~ determined during the energy scan.

Nucleoside analysis by mass spectrometry {#SEC2-6}
----------------------------------------

Total RNA was extracted from *E. coli* strain BW25113 cultured in LB broth for 18 h, using the acidic phenol method as reported previously ([@B20]). Total nucleosides were prepared by digesting *E. coli* total RNA with nuclease P1 (Wako Pure Chemical Industries) and bacterial alkaline phosphatase (BAP) (*E. coli* strain C75, TAKARA BIO INC.) under acidic conditions ([@B31]). For these reactions, a solution (typically 40 μl) containing 1 μg/μl total RNA, 20 mM trimethylamine-acetate (pH 5.3), nuclease P1 (0.1 units for 40 μg of RNA), and BAP (0.16 units for 40 μg of RNA) was incubated at 37°C for 1 h.

Total nucleosides were analyzed using a Q Exactive hybrid Quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific) equipped with an ESI source and Ultimate 3000 liquid chromatography system (Dionex). For HILIC/ESI-MS ([@B31]) was performed using a ZIC-cHILIC column (3 μm particle size, 2.1 × 150 mm, Merck Millipore). The mobile phase consisted of 5 mM ammonium acetate (pH 5.3) (solvent A) and acetonitrile (solvent B). Total nucleosides (2 μg) or synthetic ct^6^A (5 pmol) dissolved in 90% acetonitrile were injected and chromatographed with a flow rate of 100 μl/min in a multistep linear gradient: 90--40% B from 0 to 30 min, 40% B for 10 min, followed by initialization to 90% B. Proton adducts of nucleosides were scanned in positive polarity mode over an *m/z* range of 110--700. ODS/ESI-MS ([@B32]) was performed on a Sunshell C18 column (2.6 μm particle size, 2.1 × 150 mm, ChromaNik Technologies) with the same solvent system described above. The gradient program was as follows: 0--40% B from 0 to 30 min, 40% B for 5 min, followed by initialization to 0% B, at a flow rate of 75 μl/min. Total nucleosides (4 μg) or synthetic ct^6^A (10 pmol) dissolved in LC/MS grade ultrapure water (Wako) were injected. Positively charged nucleosides were scanned over an *m/z* range of 200--500. For higher-energy collision-induced dissociation (CID) in ODS/ESI-MS, the following gradient program was used: 0--15% B from 0 to 30 min with a curved gradient, 15--60% B from 30 to 35 min, 60% B for 10 min, followed by initialization to 0% B, at a flow rate of 75 μl/min. Bases liberated from nucleosides by in-source fragmentation (20 eV) were scanned over an *m/z* range of 240--400, and further scanned by data-dependent HCD with a normalized collision energy of 30. Total nucleosides (12 μg) or synthetic ct^6^A (400 pmol) dissolved in LC/MS grade ultrapure water were subjected to this analysis.

Epimerization of ct^6^A {#SEC2-7}
-----------------------

For synthetic nucleosides, 4 nmol of [l]{.smallcaps}-ct^6^A or [d]{.smallcaps}-*allo*-ct^6^A was dissolved in 400 μl of 100 mM sodium borate buffer (pH 9.0) and incubated at 37°C for 5 min, followed by adding 10 μl of 3 M NaOAc (pH 5.2) to stop the reaction. The nucleosides were desalted by using Oasis HLB cartridge (3 ml, 30 mg, Waters), dried *in vacuo* and dissolved in water. 10 pmol of each sample was subjected to ODS/ESI-MS as described above.

For natural ct^6^A, 160 μg of *E. coli* total RNA in 400 μl of 100 mM sodium borate buffer (pH 9.0) was incubated at 37°C for 15 min, followed by adding 40 μl of 3 M NaOAc (pH 5.2) to stop the reaction and subjected to ethanol precipitation to recover total RNA. Nucleoside preparation was carried out by one-step acidic digestion ([@B31]) as described above. Four microgram of total nucleoside was subjected to ODS/ESI-MS. For co-injection analysis, 10 pmol of [d]{.smallcaps}-*allo*-ct^6^A was mixed.

For amine adduct formation, 4 nmol of [l]{.smallcaps}-ct^6^A or [d]{.smallcaps}-*allo*-ct^6^A, or 160 μg of *E. coli* total RNA was dissolved in 400 μl of 100 mM Tris--HCl (pH 8.5) and incubated at 37°C for 3 h. Further preparation was performed as the same procedure described above.

RESULTS {#SEC3}
=======

Chemical synthesis of ct^6^A {#SEC3-1}
----------------------------

As reported previously ([@B24]), 5΄,3΄,2΄-*O*-acetylated derivative of [l]{.smallcaps}-ct^6^A was synthesized by dehydration of sugar protected [l]{.smallcaps}-t^6^A with acetic anhydride, while for [l]{.smallcaps}-ct^6^A preparation carbodiimide chemistry was applied ([@B20]). Here, for multimilligram scale synthesis, we used polymer-bound EDC as the activating agent for the carboxyl group of t^6^A. After the reaction, the polymer-bound EDC and its urea form product were removed by filtration, and the product was separated by silica gel column chromatography. The purity of the products was confirmed by HPLC analysis (Figure [1B](#F1){ref-type="fig"}). Yields of [l]{.smallcaps}-ct^6^A nucleoside synthesized in water and DMF as solvents were 49% and 51%, respectively. The resultant [l]{.smallcaps}-ct^6^A nucleoside was characterized by UV (Figure [1C](#F1){ref-type="fig"}), IR ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}), ^1^H NMR ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}), ^13^C NMR ([Supplementary Figure S3B](#sup1){ref-type="supplementary-material"}) and MS ([Supplementary Figure S7](#sup1){ref-type="supplementary-material"}); the results were identical to those reported previously ([@B20]).

We also synthesized diastereoisomer of ct^6^A with [d]{.smallcaps}-*allo*-threonine (Cα epimer) to examine possible epimerization of [l]{.smallcaps}-ct^6^A under mild alkaline conditions. First, we obtained [d]{.smallcaps}-*allo*-t^6^A nucleoside that was subjected to the cyclization with the same procedure as for [l]{.smallcaps}-ct^6^A nucleoside. The resultant [d]{.smallcaps}-*allo*-ct^6^A nucleoside was characterized by IR ([Supplementary Figure S4B](#sup1){ref-type="supplementary-material"}), ^1^H NMR ([Supplementary Figure S5B](#sup1){ref-type="supplementary-material"}) and ^13^C NMR ([Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}). [l]{.smallcaps}-ct^6^A and [d]{.smallcaps}-*allo*-ct^6^A nucleosides were clearly separated by HPLC analysis ([Supplementary Figure S8](#sup1){ref-type="supplementary-material"}).

Hydantoin isoform of ct^6^A revealed by crystal structure {#SEC3-2}
---------------------------------------------------------

The ct^6^A nucleoside crystallized as the monohydrate in an orthorhombic crystal system of space group *P*2~1~2~1~2~1~. Additional X-ray crystallography data are summarized in [Supplementary Tables S1--S5](#sup1){ref-type="supplementary-material"}. Strikingly, the crystal structure showed that the *N*^6^-substituent of ct^6^A adopts the hydantoin form (Figure [2A](#F2){ref-type="fig"}), rather than the previously assigned oxazolone form (Figure [1A](#F1){ref-type="fig"}). This observation prompted us to check whether the isomerization occurs during the crystallization. However, careful analysis of ct^6^A nucleoside by TLC and HPLC before and after crystallization (data not shown) revealed that no isomerization occurred during this process.

![Crystal structure of chemically synthesized ct^6^A. (**A**) Crystal structure of the hydantoin isoform of ct^6^A. Displacement ellipsoids were drawn at the 50% probability level. Hydrogen atoms are represented by circles with an arbitrary radius. (**B**) Crystal packing of ct^6^A. Hydrogen bonds are indicated by dashed blue lines.](gkw1189fig2){#F2}

In this structure, the hydrogen bonds between molecules play a vital role in crystal packing ([Supplementary Table S6](#sup1){ref-type="supplementary-material"}). In particular, the N3 nitrogen forms a strong intermolecular bond with 5΄-OH in the ribose, stabilizing the *syn* conformation of the ct^6^A base (Figure [2A](#F2){ref-type="fig"}). The water molecule localized in the crystal links O3΄ of the ribose and O10 in the hydantoin ring from another molecule. These interactions enable formation of unique crystal packing with an infinite layer of sugar rings perpendicular to the \[001\] direction (Figure [2B](#F2){ref-type="fig"}).

Detailed structure of hydantoin ct^6^A {#SEC3-3}
--------------------------------------

The bond lengths and valency angles in the adenosine and hydantoin moieties of ct^6^A ([Supplementary Tables S3 and S4](#sup1){ref-type="supplementary-material"}) are consistent with the respective values observed in crystal structures of similar chemical compounds deposited in the Cambridge Structural Database (CSD) ([Supplementary Table S5](#sup1){ref-type="supplementary-material"}) ([@B30]). The only significant difference in the ct^6^A nucleoside is the C6--N6 bond, which is longer (1.407(4) Å) than the corresponding bond in the structure of t^6^A nucleoside (1.3784(3) Å). This difference can be explained by repulsive interactions between the carbonyl oxygens of the ct^6^A hydantoin ring and the N1 and N7 nitrogens of the adenine moiety (Figure [1A](#F1){ref-type="fig"}). Similarly, elongated C6--N6 bond (1.413 Å) was found in the crystal structure of adenyl-N^6^-tetramethylsuccinimide (CSD-PULQIX), a modified adenosine with a cyclic imide containing the N6 nitrogen ([@B33]).

The ureido functionality in the ct^6^A hydantoin ring exhibits a significant electron density delocalization ([Supplementary Figure S9](#sup1){ref-type="supplementary-material"}). The elongated C10--N6 bond (1.428(4) Å) accompanied by the short C10--N11 bond (1.337(5) Å) ([Supplementary Table S3](#sup1){ref-type="supplementary-material"}) indicate a possibility of tautomeric conversion to the enol form with protonation at O10, which is additionally stabilized by hydrogen bonding with a nearby water molecule. Similarly, in the t^6^A structure, the ureido group is also influenced by electron density delocalization as indicated by relatively long C10--N6 (1.4089(3) Å) and short C10--N11 ((1.3216(3) Å)) bonds ([@B34],[@B35]).

The relative orientation of the hydantoin and adenine rings in the ct^6^A crystal structure is described by the η(N1--C6--N6--C13) dihedral angle. It adopts value of -52.7(5)°, clearly indicating twisting arrangement of those rings (Figure [2A](#F2){ref-type="fig"} and Table [1](#tbl1){ref-type="table"}). It is stabilized by the repulsive interactions between carbonyl oxygens of the hydantoin ring and the N1 and N7 nitrogens of the adenine moiety ([Supplementary Figure S9](#sup1){ref-type="supplementary-material"}). This repulsion restricts free rotation around C6--N6 bond. Indeed, an *ab initio* energy rigid scan over the η angle revealed two rotation barriers around *η* = 0° (Δ*E* = 23.0 kcal) and *η* = 180° (Δ*E* = 17.7 kcal) arising from the plane arrangement of these two rings (Figure [3](#F3){ref-type="fig"}). The dihedral angle *η* = −52.7(5)° observed in the crystal is close to the most stable conformation determined by the rigid energy scans (Figure [3](#F3){ref-type="fig"}). Similar rotation barriers were also observed by the relaxed energy scan ([Supplementary Figure S10](#sup1){ref-type="supplementary-material"}). The corresponding twisted arrangement of two rings was found in the crystal structure of adenyl-*N*^6^-tetramethylsuccinimide (CSD-PULQIX) with a corresponding dihedral angle *η* = −43.3° ([@B33]).

###### Selected dihedral angles (°) of ct^6^A and t^6^A

  Dihedral angles                  ct^6^A     t^6^A
  -------------------------------- ---------- ------------
  **N6 substituent arrangement**              
  N1--C6--N6--C13 (η)              −52.7(5)   −1.54(5)
  **Nucleoside conformation**                 
  C4΄--O4΄--C1΄C2΄ (*ν*~0~)        −23.1(4)   −21.31(5)
  O4΄--C1΄--C2΄--C3΄ (*ν*~1~)      35.9(3)    31.72(5)
  C1΄--C2΄--C3΄--C4΄ (*ν*~2~)      −34.1(3)   −29.49(5)
  C2΄--C3΄--C4΄--O4΄ (*ν*~3~)      22.0(4)    17.99(5)
  C3΄--C4΄--O4΄--C1΄ (*ν*~4~)      0.4(4)     1.95(5)
  O5΄--C5΄--C4΄--C3΄ (γ)           48.4(4)    57.23(5)
  O5΄--C5΄--C4΄--O4΄ (γ-)          −71.0(4)   −63.76(5)
  C4--N9--C1΄--O4΄ (χ)             51.0(4)    −153.41(5)

![*Ab initio* energy calculation for the rigid scan over the dihedral angle *η*. The rigid energy scan over the dihedral angle *η*(N1--C6--N6--C13) was performed at 10° steps using **t**he hybrid functional M062x and aug-cc-pvdz Dunning\'s basis set. Initial atomic coordinates were obtained from the crystal structure. Δ*E* is calculated as the E~M062x~ difference between the coordinates of each conformer and the initial coordinates. Structural models of ct^6^A are depicted at the indicated *η* angles.](gkw1189fig3){#F3}

The ribose of ct^6^A adopts the C2΄-*endo* pucker conformation (Figure [2A](#F2){ref-type="fig"}) with the values of endocyclic torsion angles *ν*~0~ − *ν*~4~ shown in Table [1](#tbl1){ref-type="table"}. The pseudorotation phase angle and puckering amplitude ([@B36],[@B37]) are *P* = 160.9(3)° and *τ*~m~ = 37.2(2)°, respectively. Because the torsion angle about the C4΄--O4΄ bond is only 0.4°, the conformation of the ribose moiety is almost exactly ^2^E. Similar sugar ring puckering was also observed in the t^6^A crystal structure, with *P* = 157.8° and *τ*~m~ = 31.8° ([@B35]).

Conformation of the 5΄-hydroxymethyl group of the ct^6^A nucleoside is described by the dihedral angle γ and γ(--) ([@B37]) and their values (Table [1](#tbl1){ref-type="table"}) define a *gauche(+)* conformation around the exocyclic C4΄--C5΄ bond. Similar conformation was also found in the t^6^A crystal structure ([@B35]).

The glycosidic dihedral angle *χ* = 51.0(4)° (Table [1](#tbl1){ref-type="table"}) clearly indicates the *syn* conformation of the ct^6^A base. It is stabilized by the intramolecular hydrogen bond between 5΄OH of sugar moiety and N3 nitrogen of heterobase. This type of interaction has not been found in crystal structure of the t^6^A nucleoside which adopts the *anti* conformation around the N-glycosidic bond ([@B35]).

Spectroscopic characterization of ct^6^A {#SEC3-4}
----------------------------------------

The ct^6^A nucleoside was further characterized by NMR spectroscopy. All ^1^H and ^13^C resonances of ct^6^A were unambiguously assigned by a combination of ^1^H,^1^H-COSY, ^1^H,^1^H-NOESY, ^1^H,^13^C-HSQC and ^1^H,^13^C-HMBC experiments, all of which are identical to our published data ([@B20]). However, these NMR analyses did not provide direct evidence allowing differentiation of the two isoforms of ct^6^A. To obtain a signature of the hydantoin isoform of ct^6^A, we further recorded ^1^H,^15^N-HSQC and ^1^H,^15^N-HMBC spectra for the ct^6^A nucleoside to determine ^15^N chemical shifts (Table [2](#tbl2){ref-type="table"} and [Supplementary Figure S11](#sup1){ref-type="supplementary-material"}). The chemical shifts of N6 (163 ppm) and N11 (87 ppm) of ct^6^A were in the range characteristic to urea-type nitrogens, consistent with the analogous nitrogens in the *N*^3^-phenyl hydantoin structure ([@B38]), supporting the idea that the hydantoin isoform actually exists in solution. In the case of the oxazolone isoform, the C=N--Ar type nitrogen would appear at much lower magnetic field ([@B39]).

###### ^15^N chemical shifts of ct^6^A and t^6^A in DMSO

         ct^6^A   t^6^A
  ------ -------- -------
  N-1    275      233
  N-3    254      236
  N-7    241      239
  N-9    171      172
  N-6    163      116
  N-11   87       93

^15^N chemical shifts (ppm) relative to liquid NH~3~.

We next obtained IR spectra of t^6^A ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}) and ct^6^A ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}). The characteristic ureido carbonyl absorption at 1680 cm^−1^ in t^6^A disappeared in the spectrum of ct^6^A, and was replaced by two absorption bands at 1780 and 1730 cm^−1^. These absorptions are in the same range as the hydantoin ring of 3-purin-6-yl-hydantoins ([@B40]), further supporting the idea that the synthetic ct^6^A adopts the hydantoin isoform.

Solution structure of hydantoin ct^6^A {#SEC3-5}
--------------------------------------

Conformation of hydantoin ct^6^A in solution was determined using NMR spectroscopy. The conformation of the ribose was inferred by vicinal spin--spin coupling constants determined by ^1^H NMR spectra in D~2~O ([Supplementary Figure S12](#sup1){ref-type="supplementary-material"}). At room temperature, the C2΄-*endo* and C3΄-*endo* conformers of ct^6^A were equally populated in solution, while in the crystal it was C2΄-*endo* sugar pucker (Figure [2A](#F2){ref-type="fig"}). Regarding exocyclic C4΄--C5΄ bond, we found that *gauche* (+) is the preferred conformation (∼62%) of ct^6^A in solution which is consistent with the result of the crystal structure.

Then, we conducted 1D NOE experiments to examine orientation of the ct^6^A base relative to the ribose ([@B41],[@B42]). When H8 was irradiated, strong NOE effect was observed to H2΄ rather than to H1΄ ([Supplementary Figure S13](#sup1){ref-type="supplementary-material"} and [Supplementary Table S7](#sup1){ref-type="supplementary-material"}), suggesting that ct^6^A predominantly takes *anti* conformation in solution. Supporting this finding, a strong cross peak of H8--H2΄, and a weak cross peak of H8--H1΄ were also observed in 2D NOESY spectrum in D~2~O ([Supplementary Figure S14](#sup1){ref-type="supplementary-material"}). All of these results confirmed the *anti* conformation of ct^6^A. This observation is not consistent with that found in the crystal structure where the ct^6^A base adopts the *syn* conformation. The relative orientation of the hydantoin and adenine rings could not be provided by NMR data analyses as there are no vicinal coupling constants available for the Karplus-like relationship.

Presence of hydantoin ct^6^A in *E. coli* tRNAs {#SEC3-6}
-----------------------------------------------

To determine whether the hydantoin isoform of ct^6^A is actually present in cellular tRNAs, we conducted LC/MS analyses to compare synthetic and natural ct^6^A. In reverse-phase column chromatography (ODS) coupled with mass spectrometry, the synthetic ct^6^A and natural ct^6^A in total nucleosides in *E. coli* tRNAs eluted at similar retention times, ∼24 min (Figure [4A](#F4){ref-type="fig"}). When both specimens were co-injected, we observed a single peak of mass chromatogram at *m/z* 394 (Figure [4A](#F4){ref-type="fig"}). In addition, we conducted the same MS analysis using hydrophilic interaction chromatography (HILIC). The synthetic and natural ct^6^A co-eluted at the same retention time as well (Figure [4B](#F4){ref-type="fig"}).

![LC/MS co-injection analyses of synthetic and natural ct^6^A nucleosides. LC/MS analyses of synthetic ct^6^A and *E. coli* total nucleosides by reverse-phase chromatography using octadecylsilyl resin (ODS, **A**), and by hydrophilic interaction chromatography (HILIC, **B**). UV traces (254 nm) and mass chromatograms (*m/z* 395) of synthetic ct^6^A (top), natural ct^6^A in *E. coli* total RNA (middle), and co-injected natural and synthetic ct^6^A (bottom). ct^6^A peaks in the UV trace are indicated by arrows.](gkw1189fig4){#F4}

Next, we performed higher-energy collision-induced dissociation (CID) analysis of the base-related ion (BH^2+^) of both synthetic and natural ct^6^A. Product ions generated from the BH^2+^ of ct^6^A (*m/z* 263) were almost identical for both specimens (Figure [5A](#F5){ref-type="fig"} and [B](#F5){ref-type="fig"}). These product ions could be assigned in the chemical structure of the hydantoin isoform of the ct^6^A base (Figure [5C](#F5){ref-type="fig"}).

![CID spectra of the ct^6^A base. CID spectra of the ct^6^A base (*m/z* 263) derived from synthetic ct^6^A nucleoside (**A**) and *E. coli* total nucleosides (**B**). (**C**) Product ions are assigned in the chemical structure of the hydantoin isoform of the ct^6^A base.](gkw1189fig5){#F5}

Epimerization of hydantoin ct^6^A under mild alkaline conditions {#SEC3-7}
----------------------------------------------------------------

When total RNA was digested into nucleosides by conventional condition (pH 8.2), most of ct^6^A was hydrolyzed and converted to t^6^A as reported ([@B20]). In this condition, we noticed appearance of second peak of t^6^A that elutes faster than the original peak of t^6^A in LC/MS chromatogram ([@B20]). In addition, rest of ct^6^A also split and gave second peak that elutes slower than the original ct^6^A peak ([@B20]). When ct^6^A was incubated with Tris buffer, two peaks of Tris-adduct of t^6^A appeared ([@B20]). These findings prompted us to speculate that α-carbon of threonine residue in hydantoin ring is epimerized under mild alkaline treatment ([Supplementary Figure S15](#sup1){ref-type="supplementary-material"}). To confirm this speculation, ct^6^A epimer ([d]{.smallcaps}-*allo*-ct^6^A) was synthesized chemically, and compared to [l]{.smallcaps}-ct^6^A treated under mild alkaline condition and/or incubated with Tris buffer. As shown in Figure [6A](#F6){ref-type="fig"}, the synthetic [l]{.smallcaps}-ct^6^A gave a single peak in LC/MS. In addition, [l]{.smallcaps}-t^6^A, a hydrolyzed product of [l]{.smallcaps}-ct^6^A, was also detected. When [l]{.smallcaps}-ct^6^A was incubated with a buffer adjusted at pH 9 for 5 min, second peak of ct^6^A that eluted slower than the [l]{.smallcaps}-ct^6^A peak clearly appeared, while second peak of t^6^A that eluted faster than the [l]{.smallcaps}-t^6^A peak was also detected. Judging from the retention times of the synthetic [d]{.smallcaps}-*allo*-ct^6^A and its hydrolysate, [d]{.smallcaps}-*allo*-t^6^A, these second peaks were found to be [d]{.smallcaps}-*allo*-ct^6^A and [d]{.smallcaps}-*allo*-t^6^A, respectively (Figures [6A](#F6){ref-type="fig"} and [Supplementary Figure S15](#sup1){ref-type="supplementary-material"}). Furthermore, when the synthetic [d]{.smallcaps}-*allo*-ct^6^A was incubated under mild alkaline conditions (pH 9 for 5 min), [l]{.smallcaps}-ct^6^A and [l]{.smallcaps}-t^6^A clearly appeared. To confirm these findings, [l]{.smallcaps}-ct^6^A treated with mild alkaline was coinjected with [d]{.smallcaps}-*allo*-ct^6^A which was treated or untreated with mild alkaline ([Supplementary Figure S16](#sup1){ref-type="supplementary-material"}). Second peaks of [l]{.smallcaps}-ct^6^A appeared under mild alkaline conditions coeluted with [d]{.smallcaps}-*allo*-ct^6^A and [d]{.smallcaps}-*allo*-t^6^A, respectively.

![Epimerization of ct^6^A. (**A**) Epimerization of synthetic [l]{.smallcaps}-ct^6^A and D-*allo*-ct^6^A under mild alkaline condition. Each nucleoside was treated with (+) or without (−) mild alkaline (pH 9 for 5 min), and subjected to ODS/ESI-MS analysis to detect ct^6^A (*m/z* 395, upper panels) and t^6^A (*m/z* 413, lower panels). A peak corresponding to each epimer is indicated in the chromatographs. (**B**) Epimerization of natural ct^6^A in *E. coli* total RNA under mild alkaline condition. *E. coli* total RNA was treated with (+) or without (−) mild alkaline (pH 9 for 15 min), digested into nucleoside under acidic condition, and subjected to ODS/ESI-MS analysis to detect UV trace at 254 nm (top panels), ct^6^A (*m/z* 395, middle panels) and t^6^A (*m/z* 413, bottom panels). (**C**) Epimerization of amine adduct of t^6^A. Synthetic ct^6^A epimers and *E. coli* total RNA were incubated with Tris buffer (pH 8.5) for 3 h. Nucleosides were analyzed by ODS/ESI-MS to detect Tris-adduct of t^6^A (*m/z* 516).](gkw1189fig6){#F6}

Next we examined epimerization of natural ct^6^A in *E. coli* tRNAs. As reported previously ([@B20]), when *E. coli* total RNA was incubated with a buffer at pH 9 for 15 min, we detected [d]{.smallcaps}-*allo*-ct^6^A along with [d]{.smallcaps}-*allo*-t^6^A (Figure [6B](#F6){ref-type="fig"}). [d]{.smallcaps}-*allo*-ct^6^A in *E. coli* total RNA was confirmed by coinjection with synthetic specimen. Moreover, we examined epimerization of t^6^A upon adduct formation with amine. When the synthetic or natural ct^6^A was incubated with Tris buffer at pH 8.5, both [l]{.smallcaps}-type and [d]{.smallcaps}-*allo*-type Tris adducts of t^6^A were generated (Figure [6C](#F6){ref-type="fig"}).

Collectively, these findings demonstrate that epimerization of ct^6^A takes place under alkaline conditions, even at pH 8.5, followed by epimer formation of t^6^A and its amine-adducts.

DISCUSSION {#SEC4}
==========

The crystal structure of the ct^6^A nucleoside clearly demonstrates that ct^6^A adopts a hydantoin isoform (Figure [2A](#F2){ref-type="fig"}), rather than the previously predicted oxazolone isoform ([@B20]). We also confirmed that the hydantoin ct^6^A is actually present in *E. coli* tRNAs (Figure [4](#F4){ref-type="fig"}). As shown here, it was impossible to differentiate the two isoforms by a series of NMR and MS analyses, explaining the reason why the chemical structure of ct^6^A was once assigned to be the oxazolone isoform. For instance, the product ions of CID spectrum of ct^6^A base (Figure [5A](#F5){ref-type="fig"} and [B](#F5){ref-type="fig"}) could be assigned to the hydantoin isoform as well as to oxazolone isoform ([Supplementary Figure S17](#sup1){ref-type="supplementary-material"}) ([@B20]). Additionally, a pattern of the scalar couplings observed in ^1^H--^1^H-COSY spectra of both isoforms is very similar. In ^1^H--^1^H-COSY spectrum of ct^6^A, we observed cross peaks between NH11--H12, H12--H14, H14--OH14 and H14--H15 attributed to the threonine side chain ([Supplementary Figure S18](#sup1){ref-type="supplementary-material"}), however, these couplings are present in both hydantoin and oxazolone isoforms. No coupling was found between amino acid side chain and adenine base. In this study, however, we have found three spectroscopic features implying the presence of a hydantoin group in ct^6^A. First, the unique chemical shift of N6 atom (163 ppm) of ct^6^A in ^15^N NMR implies the existence of hydantoin structure (Table [2](#tbl2){ref-type="table"}). Second, the chemical shift of NH11 proton (9.72 ppm) of t^6^A moved toward high magnetic field by 1 ppm (8.72 ppm) in ct^6^A ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}), supporting the fact that hydrogen bond of NH11--N1 is impossible in the hydantoin isoform (Figure [1A](#F1){ref-type="fig"}). Third, two characteristic absorption bands at 1780 and 1730 cm^−1^ in the IR spectrum of ct^6^A nucleoside ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}) also indicate carbonyl bond stretching in the hydantoin ring.

TcdA catalyzes ATP-dependent dehydration of t^6^A to form ct^6^A on tRNA ([@B20]). Given that TcdA is a ubiquitin-activating E1-like protein with ATPase activity, it is likely that it first adenylates the carboxyl group of t^6^A to form an activated ester intermediate, and subsequently allows the N6 nitrogen of t^6^A to attack the C13 carbon to cyclize the side chain with release of AMP. This reaction mechanism resembles the chemical synthesis of ct^6^A using a carbodiimide-type activating reagent such as EDC. Intriguingly, a previous study reported hydantoin ring formation of the t^6^A base using *N*,*N*'-dicyclohexylcarbodiimide (DCC) ([@B40]). The activated ester intermediate of t^6^A with EDC or DCC is analogous to the adenylate intermediate of t^6^A generated by TcdA.

ct^6^A is easily hydrolyzed to convert to t^6^A under mild alkaline conditions ([@B20]). In addition, primary amines such as tris(hydroxymethyl)aminomethane or ethanolamine react efficiently with ct^6^A to generate amides of t^6^A ([@B20],[@B43],[@B44]). The hydantoin ct^6^A (Figure [1A](#F1){ref-type="fig"}) has two carbonyl carbons, C10 and C13, both of which could potentially be attacked by a water molecule or an amine. According to the general hydantoin chemistry, the non-ureido carbonyl carbon of a hydantoin compound is more susceptible to the reaction with nucleophiles, yielding the hydantoic acid and its derivatives ([@B45]--[@B47]). Thus, in the case of ct^6^A, C13 carbonyl carbon is naturally targeted by hydrolysis ([@B20],[@B40]) and amine adduct formation ([@B20],[@B43],[@B44]), whereas the ureido C10 is comparatively non-reactive. In addition, we here showed that hydantoin ct^6^A is susceptible to epimerization under mild alkaline conditions, indicating that H12 in hydantoin ring is acidic enough for such process ([@B48],[@B49]). It was shown that hydantoin derivatives are racemized as the result of tautomeric change ([@B50]). Just for 5 min incubation of [l]{.smallcaps}-ct^6^A at pH 9, 20--30% of [l]{.smallcaps}-ct^6^A is epimerized to yield [d]{.smallcaps}-*allo*-ct^6^A, and then it is hydrolyzed to form [d]{.smallcaps}-*allo*-t^6^A. The epimerization of ct^6^A and t^6^A also takes place at pH 8.2 under conventional nucleoside preparation ([@B20]). For tRNA preparation used for *in vitro* translation or other biochemical experiments, aminoacyl-moieties attached to 3΄ termini of aa-tRNAs isolated from the cell are frequently removed by mild alkaline treatment. According to the original methods, tRNA fractions extracted from the cell are incubated with 500 mM Tris-HCL (pH 8.8) ([@B51]) or 200 mM glycine buffer (pH 10.3) ([@B52]) for their deacylation. In these conditions, ct^6^A in tRNAs should be epimerized and converted to [l]{.smallcaps}-t^6^A and [d]{.smallcaps}-*allo*-t^6^A as well as Tris- and glycine-adducts of t^6^A, respectively. If [d]{.smallcaps}-*allo*-ct^6^A and [d]{.smallcaps}-*allo*-t^6^A have different activity in protein synthesis from their [l]{.smallcaps}-isomers, translational activity of tRNAs having ct^6^A should be reconsidered carefully. From these findings, we have learned that usage of primary amines and mild alkaline conditions should be avoided to handle and prepare tRNAs bearing ct^6^A.

As shown in the crystal structure of ct^6^A nucleoside, the hydantoin ring adopts a twisted position with a torsion angle of −52.7° against the adenine base (Figure [2A](#F2){ref-type="fig"}). From the *ab initio* energy calculation of hydantoin ring rotation, we identified four energy minimum rotamers with different η dihedral angles (127.3°, 67.3°, −52.7° and −122.7°) between the hydantoin and adenine rings (Figure [3](#F3){ref-type="fig"}). They all have 'twisted conformation' due to repulsive interaction between carbonyl oxygens of the hydantoin ring and the N1 and N7 nitrogens of the adenine moiety. In fact, actual conformation of ct^6^A in the crystal structure adopts one of these energy minimum rotamers. Although we do not have any experimental evidence to determine the orientation of the rings in solution, it is quite natural to assume that ct^6^A adopts 'twisted conformation' in solution, because repulsive interaction between the two rings should come from very basic chemical nature of ct^6^A. Strong rotational barriers (23 and 17.7 kcal) of the planar arrangement of the two rings of ct^6^A (Figure [3](#F3){ref-type="fig"}) restrict free rotation of C6--N6 bond. However, given that these barriers can be overcome by heat energy at normal growth temperatures, the hydantoin ring might be able to rotate to some extent under physiological conditions.

As observed in the crystal structure of the t^6^A37-containing anticodon stem--loop recognizing the AAG codon at the ribosomal A site ([@B16]), the N1--NH11 hydrogen bond extends a planar adenine base that stabilizes codon--anticodon pairing as well as the anticodon stem--loop structure. One possible structural model of the oxazolone ct^6^A ([@B20]) indicated that the oxazolone ring favors being fixed at the planar position with the adenine base to extend its π-conjugated system, enabling a strong stacking interaction with the codon--anticodon helix. This model provides a potential molecular basis for the contribution of ct^6^A to recognition of the adenine base of the ANN codon. However, the hydantoin ring of ct^6^A cannot adopt a planar position with the adenine base due to strong coulombic repulsion between the two rings. If there is no conformational restriction in the decoding center, the hydantoin ct^6^A may adopt one of the four twisted conformations on the ribosome. Taking account of the twisted conformation and low probability of π--π stacking of the hydantoin ring, it is an enigmatic issue how the twisted hydantoin ring stabilizes codon--anticodon interaction at the ribosomal A-site. Structural studies of 70S ribosome complexed with tRNA with ct^6^A37 and its cognate codon will be required to reveal the actual conformation of the hydantoin ring at the decoding center.

We here confirmed that the hydantoin isoform of ct^6^A is present in *E. coli* tRNAs. Presumably, this isoform is present in tRNAs from other organisms. However, we cannot rule out the possibility that the oxazolone isoform of ct^6^A may serve as an intermediate of the hydantoin isoform during biogenesis of ct^6^A.

AVAILABILITY {#SEC5}
============

Crystallographic data (excluding structure factors) for the structures reported herein, have been deposited with the Cambridge Crystallographic Data Centre under accession number CCDC 1458975. Copies of the data can be obtained free of charge at <http://www.ccdc.cam.ac.uk/>.
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